This opportunity funds institutions to establish or maintain a Pharmacokinetics Resource Laboratory supporting the Experimental Therapeutics Clinical Trials Network. Funded labs will organize biospecimen collections and analyze pharmacokinetic endpoints, drug interactions, pharmacodynamics, and food effects in early phase clinical trials of NCI Investigational New Drug agents, advancing clinical development through multidisciplinary expertise.
Eligible applicants include private and public institutions of higher education, for-profit organizations excluding small businesses, small businesses, nonprofits without 501(c)(3) status, and others as specified in additional eligibility information.
